date,title,source
Nov-08-18,Stemline Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Stemline Therapeutics Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-16-18,Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at the 23rd Annual Meeting of the Society of Neuro-Oncology (SNO),GlobeNewswire
Nov-20-18,Stemline Therapeutics Announces that European Medicines Agency (EMA) Grants Accelerated Assessment for planned ELZONRIS Marketing Authorization Application (MAA),GlobeNewswire
Nov-21-18,What Kind Of Investor Owns Most Of Stemline Therapeutics Inc (NASDAQ:STML)?,Simply Wall St.
Nov-27-18,"Report: Developing Opportunities within Koppers, Flowers Foods, Stemline Therapeutics, Aqua Metals, athenahealth, and Bojangles'  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-30-18,"Stemline Therapeutics Highlights Four ELZONRIS Presentations, Including an Oral Presentation, at the Upcoming ASH Meeting",GlobeNewswire
Dec-06-18,Stemline Therapeutics Recaps Key Clinical Data Presentations from the American Society of Hematology (ASH) Annual Meeting,GlobeNewswire
